Related Experiment Video

Updated: Dec 18, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.7K

Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Shijia Zhang1, Ryan Shanley2, Daniel J Weisdorf1

  • 1Division of Hematology, Oncology, and Transplantation, Department of Medicine, and.

Blood Advances
|June 20, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.6K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.2K

Related Experiment Videos

Last Updated: Dec 18, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.7K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.6K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.2K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

722
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
722
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

82.9K
Overview
82.9K

Articles linked to this work by shared authors, journal, and citation graph.

Identification of Microbiome Associations with Tacrolimus Pharmacokinetics in Adult Hematopoietic Cell Transplantation Using Population Pharmacokinetic and Machine Learning.

Pharmaceutical research·2026

Cohesive modules of engraftment in fecal microbiota transplantation.

iScience·2026

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

bioRxiv : the preprint server for biology·2026

Longitudinal Multicompartment Oral Mucositis Assessment in Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Contemporary Prospective Cohort Analysis.

Transplantation and cellular therapy·2026

Antibiotic risk score for acute graft-versus-host disease.

Blood advances·2025

Dental plaque microbiota following allogeneic hematopoietic cell transplantation and risk of chronic graft-versus-host disease.

Haematologica·2025

Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

Blood advances·2026

A Synthetic, Small Molecule, Allosteric Inhibitor of Human Factor XIa for Thrombosis.

Blood advances·2026

Cumulative Stress Measured by Allostatic Load is Associated with Vaso-Occlusive Episodes in Sickle Cell Disease.

Blood advances·2026

T-cell dynamics, CD8/NK ratio and tumor survival hallmarks determine response to T-cell bispecific forimtamig in myeloma.

Blood advances·2026

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Blood advances·2026

Systematic Review and Meta-Analysis of Hypersensitivity Reactions after High-dose Intravenous Iron.

Blood advances·2026

Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.

Reviews on recent clinical trials·2026

A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing.

Microbiology spectrum·2026

Correction to "Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026".

Pregnancy (Hoboken, N.J.)·2026

When meta-analyses mislead: Promises and pitfalls in teratology counselling.

British journal of clinical pharmacology·2026

Antibacterial efficacy of Nonea lutea-mediated silver and gold nanoparticles against multidrug-resistant clinical pathogens harboring virulence and resistance genes.

International microbiology : the official journal of the Spanish Society for Microbiology·2026

Ethical, legal, and societal implications in xenotransplantation (ELSI): a Korean regulatory perspective.

Clinical transplantation and research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us